Healthcare - Biotechnology - NASDAQ - US
$ 9.17
-9.21 %
$ 525 M
Market Cap
-5.12
P/E
INCOME STATEMENT
0
REVENUE
-105 M
OPERATING INCOME
-96.7 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Olema Pharmaceuticals, Inc.
| Revenue | 0 |
| Cost Of Revenue | 377 K |
| Gross Profit | -377 K |
| Operating Expenses | 105 M |
| Operating Income | -105 M |
| Other Expenses | -8.31 M |
| Net Income | -96.7 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 0.4 | 1.7 | 1.7 | 11 K | 9.03 K | 8.24 K |
| Gross Profit | (0.4) | (1.7) | (1.7) | 11 K | 9.03 K | 8.24 K |
| OPERATING INCOME | ||||||
| Operating Expenses | 105.0 | 107.0 | 71.5 | 21.5 | 4.3 | 2.1 |
| Selling, General and Administrative Expenses | 18.8 | 24.7 | 20.4 | 7.8 | 0.4 | 0.4 |
| Research and Development Expenses | 86.1 | 82.3 | 51.1 | 13.7 | 3.9 | 1.7 |
| Operating Income | (105.0) | (107.0) | (71.5) | (21.5) | (4.3) | (2.1) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | (0.4) | 0 | 0.7 | 0 | 28 K |
| Total Other Income | 8.3 | 2.2 | 0.4 | (0.6) | 7 K | (0.1) |
| Pre-Tax Income | (96.7) | (104.8) | (71.1) | (22.1) | (4.3) | (2.2) |
| NET INCOME | ||||||
| Tax Provision | 0 | (2.2) | (0.2) | 0.6 | (0.2) | 90 K |
| Net Income | (96.7) | (102.6) | (70.9) | (22.8) | (4.3) | (2.2) |
| EPS | 2.14 | 2.56 | 1.79 | 0.58 | 0.11 | 0.16 |